Could a tiny sensor replace the glucose drink test for new moms?
NCT ID NCT06184373
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a continuous glucose monitor (CGM) — a small sensor worn under the skin — is an acceptable and useful tool for checking diabetes risk in women who recently had gestational diabetes. Twenty women will wear the CGM for 10 days at 6-8 weeks after giving birth, then complete surveys about their experience. The goal is to see if CGM could improve low follow-up rates for postpartum diabetes screening.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
continuous glucose monitor (CGM)
What this could lead to
If successful, this could show that CGM is a practical and acceptable way to screen for diabetes risk after gestational diabetes, potentially improving follow-up care.
What could go wrong
This is a very small early study (20 participants) focused on acceptability, not on proving that CGM prevents diabetes. Results may not apply to all women.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State University Medical Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••